Archive
SHIFT 2024 Summary: Evolving Phenotypes in the Cystic Fibrosis Population
In this summary, we review key points, next steps, and actions arising from the presentations and cross-disciplinary panel discussion held during the SHIFT 2024 symposium (4 August 2024), which considered current knowledge, discussed future trends and explored opportunities to support best-practice care for emerging versus classic CF disease phenotypes in the CFTR modulator era. Read More
Read MoreSHIFT Masterclass: Monitoring Health and Disease Progression in the CFTR Modulator Era
Prepared by A/Prof Tonia Douglas, this SHIFT Masterclass examines clinical challenges and gaps, and underscores opportunities to reconsider how and what we monitor in CF, to ensure it is clinically relevant and supports optimal health outcomes for patients in this new era of CF. These valuable insights were summarised from a comprehensive cross-disciplinary discussion held during Session 4 at SHIFT 2023 (11 November 2023). Read More
Read MoreSHIFT Masterclass: Adherence Challenges and Maintaining Engagement in the Era of CFTR Modulators
Prepared by A/Prof Tonia Douglas, this SHIFT Masterclass examines clinical challenges and gaps, and underscores opportunities related to adherence challenges and maintaining engagement in the CFTR modulator era. These valuable insights were summarised from a comprehensive cross-disciplinary discussion held during Session 5 at SHIFT 2023 (11 November 2023). Read More
Read MoreSHIFT 2023: Next Steps and Actions Towards Shifting Models of Care in CF – How Do We Get Started?
A summary of next steps and actions towards shifting models of care in CF, arising from the cross-disciplinary panel discussion held following the SHIFT 2023 symposium (17 November 2023). Read More
Read MoreSHIFT Masterclass: Mental Health Models of Care and the CF MDT
Read key points and review challenges, gaps, implications and opportunities for mental and psychosocial health in CF, as discussed during the SHIFT 2022 session on mental health models of care and the CF multidisciplinary team (MDT), held on 12 November 2022. Read More
Read MoreSHIFT Masterclass: Mental and Psychosocial Health in CF During Perinatal, Early Childhood and Primary School Age Life Stages
Read key points and review challenges, gaps, implications and opportunities for mental and psychosocial health in CF, as discussed during the SHIFT 2022 sessions on perinatal, early childhood and primary school age life stages, held on 11 November 2022. Read More
Read MoreSHIFT Masterclass: Mental and Psychosocial Health in Cystic Fibrosis: Life Stage – Adolescence and Young Adulthood (AYA)
Read key points and review challenges, gaps, implications and opportunities for Mental and psychosocial health in cystic fibrosis, as discussed during the SHIFT 2022 session 3 on Life stage – Adolescence and young adulthood, held on 11 November 2022. Read More
Read MoreSHIFT Masterclass: Mental Health within CF Multidisciplinary Teams
Read key points and review challenges, gaps, implications and opportunities for mental and psychosocial health in CF, as discussed during the SHIFT 2022 session on the impact of mental health within CF multidisciplinary teams (MDTs), held on 12 November 2022. Read More
Read MoreSHIFT Masterclass: Impact of Mental Health on Health Behaviours and Treatment Adherence
Read key points and review challenges, gaps, implications and opportunities for Mental and psychosocial health in cystic fibrosis, as discussed during the SHIFT 2022 session on, the impact of mental health on health behaviours and treatment adherence, held on 12 November 2022. Read More
Read MoreSHIFT 2021 Summary: Next Steps and Actions Towards Multidisciplinary Management of Extrapulmonary Disease in CF
A summary of next steps and actions towards multidisciplinary management of extrapulmonary disease in CF, arising from the cross-disciplinary panel discussion held during the SHIFT 2021 symposium (28 November 2021). Read More
Read More